Business profile

Genobiomics Oy

Genobiomics Oy's registered office is Oulu. It is a limited company. The company was established on 2018-10-19. It operates in the industry of research and experimental development on natural sciences and engineering.

Business ID 2943937-5ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
2943937-5
Sector
Research and experimental development on natural sciences and engineering
Municipality
Oulu
Company form
Limited company
Registration date
2018-10-19
Business ID registration date
2018-10-03
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Rantakukantie 1 B 10, 90540, Oulu

Phone: +358406303377Source observation

Email: [email protected]Source observation

Website: https://www.genobiomics.comSource observation

Linkedin profile: https://www.linkedin.com/company/genobiomicsSource: company website

People and decision-makers

Mysore Vishakante Gowda TejesviToimitusjohtaja

About Genobiomics Oy

Financial position and key figures for the company.

Genobiomics Oy's location municipality is Oulu. It is a limited company. The company was established on 2018-10-19. It operates in the industry of research and experimental development on natural sciences and engineering. Based on the latest retained statement, revenue growth was not currently available, operating margin was not currently available, and equity ratio was +100.0%.

Financial highlights

Key figures from the latest financial period.

Latest financial period

2025-12-31

Imported periods0
PRH parsed0
Profile sourceEnriched source observation
Derived indicators
Equity ratio100.0%
Balance-sheet contextLatest financial period
Profit before taxes-€1,420Previous: -€1,971
Employees0Previous: 0
Revenue trend2 periods
€7,250
2021-12-31
€0
2022-12-31
Operating profit (loss) trend5 periods
€5,342
2021-12-31
-€2,198
2022-12-31
-€3,266
2023-12-31
-€1,965
2024-12-31
-€1,420
2025-12-31
Profit (loss) for the financial year trend5 periods
€4,274
2021-12-31
-€1,911
2022-12-31
-€3,266
2023-12-31
-€1,971
2024-12-31
-€1,420
2025-12-31
Assets trend5 periods
€9,998
2021-12-31
€8,060
2022-12-31
€4,794
2023-12-31
€2,823
2024-12-31
€1,402
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: Rikastettu lähdehavainto.

Equity ratioGood
100/100 · Stable
100.0 %2024-12-31: 100.0 %
Current ratioNot assessable
0/100 · Trend unavailable
Not available2024-12-31: Ei saatavilla
Operating profit marginNot assessable
0/100 · Trend unavailable
Not available2021-12-31: 73.7 %
Ratio history
Ratio2021-12-312022-12-312023-12-312024-12-312025-12-31
Equity ratio100.0 %100.0 %100.0 %100.0 %100.0 %
Current ratio-----
Operating profit margin73.7 %----

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID2943937-5
EU IDFIFPRO.2943937-5
MunicipalityOulu
Current registered entries
2018-10-03Registered in Tax Administration (Prepayment Register)
2018-10-19Registered in Patent and Registration Office (Trade Register)
2018-10-29Registered in Tax Administration (Tax Administration)

Responsible people

Public role relationships materialized from source observations.

Mysore Vishakante Gowda TejesviToimitusjohtajaSources: 5 · Confidence: 78%
Mysore Vishakante Gowda TejesviVarsinainen jäsenSources: 2 · Confidence: 78%
Vänni Petri MikaelOikeutettu nimenkirjoittajaSources: 1 · Confidence: 78%
Lingaiah ShilpaVarajäsenSources: 2 · Confidence: 78%

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
B1
StableGenobiomics Oy
Model score68/100
Assessment confidenceLow
Evidence qualityUsable financial evidenceFinancial data included
Financial trajectoryFinancial development is mostly stable or mixed.
4 comparable periods
RevenueNot enough history
ProfitabilityNot enough history
SolvencyStable
LiquidityNot enough history
Peer comparisonNational Tier 1 comparisonDescriptive comparison – does not change the model score.
320 peers
Solvency96%
Better than 96% of peers
Supporting factors
  • Strong equity ratio
  • Active registered status
Risk factors to note
  • Negative profitability or net result
  • Losses in the latest and previous available periods
  • Elevated industry distress context
Automatic model gradeB1
Automatic model snapshot2026-10-11
Automatic model versionopen-risk-grade-v0.14
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskelevated
48/100

Industry context is elevated based on normalized open statistical inputs.

Age and continuityHyvä
60/100

The company has about 7 years of registry continuity.

Registry and status signalsSeurattava
60/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
11 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.

Registry timeline

Trade register notifications shown on a timeline.

15 register eventsLatest event: 2025-04-26

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Genobiomics Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.